The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer

Diseases of the Colon and Rectum

Volumn 51, Issue 7, 2008, Pages 997-1003

  Davey, K ^a   Heriot, A G ^a   Mackay, J ^a   Drummond, E ^a   Hogg, A ^a   Ngan, S ^a   Milner, A D ^a   Hicks, R J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Positron emission tomography computed tomography; Rectal cancer; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; RECTUM CANCER; TREATMENT PLANNING; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 46649115496     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-008-9244-1     Document Type: Article

References (29)

1. Ruo L, Guillem J. Major 20th-Century advances in the management of rectal cancer. Dis Colon Rectum 1999;42:563-78.
2. Martling A, Holm T, Rutqvist L-E, Moran B, Heald R, Cedermark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group. Basingstoke Bowel Cancer Research Project. Lancet 2000;356:93-6.
3. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358:1291-304.
4. Gibbs P, Chao M, Tjandra J. Optimizing the outcome for patients with rectal cancer. Dis Colon Rectum 2003;46:389-402.
5. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40.
6. Nicholls RJ, Galloway DJ, Mason AY, Boyle P. Clinical local staging of rectal cancer. Br J Surg 1985;72(Suppl):S51-2.
7. Schaffzin D, Wong W. Endorectal ultrasound in the preoperative evaluation of rectal cancer. Clin Colorectal Cancer 2004;4:124-32.
8. Heriot A, Grundy A, Kumar D. Preoperative staging of rectal carcinoma. Br J Surg 1999;86:17-28.
9. Beets-Tan R, Beets G, Vliegen R, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer. Lancet 2001;357:497-504.
10. Brown G, Kirkham A, Williams GT, et al. High-resolution MRI of the anatomy important in total mesorectal excision of the rectum. AJR Am J Roentgenol 2004;182:431-9.
11. MacManus M, Hicks R, Mathews J, et al. High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small cell lung cancer: implications for radical radiotherapy. Int J Radiat Oncol Biol Phys 2001;50:287-93.
12. Blum R, Seymour J, Wirth A, et al. Frequent impact of (18F) fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma. Clin Lymphoma 2003;4:43-9.
13. Leong T, Everitt C, Hichs R, et al. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol 2006;78:254-61.
14. Meta J, Seltzer M, Schiepers C, et al. Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective. J Nucl Med 2001;42:586-90.
15. Kalff V, Hicks R, Ware R, Hogg A, Binns D, McKenzie A. The clinical impact of 18F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med 2002;43:492-9.
16. Heriot A, Keck J, Mackay J, et al. A prospective assessment of the impact of PET in primary rectal cancer: does it change management? Dis Colon Rectum 2004;47:451-8.
17. Even-Sapir E, Parag Y, Lerman H, et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 2004;232:815-22.
18. Gearhart S, Frassica D, Rosen R, Choti M, Schulick R, Wahl R. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Ann Surg Oncol 2006;13:397-404.
19. Balch G, De Meo A, Guillem J. Modern management of rectal cancer: a 2006 update. World J Gastroenterol 2006;12:3186-95.
20. Heriot A, Kumar D. Rectal cancer recurrence: factors and mechanisms. Colorectal Dis 2000;2:126-37.
21. Weber W, Ott K, Becker K, et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 2001;19:3058-65.
22. Guillem J, Puig-La Calle JJ, Akhurst T, et al. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum 2000;43:18-24.
23. Calvo F, Domper M, Matute R, et al. 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 2004;58:528-35.
24. Chessin D, Kiran R, Akhurst T, Guillem J. The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer. J Am Coll Surg 2005;201:948-56.
25. Garcia-Aguilar J, Hernandez De Anda E, Sirivongs P, et al. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003;46:298-304.
26. Guillem J, Moore H, Akhurst T, et al. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining long-term outcomes of rectal cancer. J Am Coll Surg 2004;199:1-7.
27. Kalff V, Duong C, Drummond E, Mathews J, Hicks R. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery. J Nucl Med 2006;47:14-22.
28. Brennan M. PET scanning in malignancy: infant, adolescent, or mature citizen? Ann Surg 2001;233:320-1.
29. Valk P, Abella-Columna E, Hasemann M, et al. Whole body PET imaging with 18-F fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 1999;134:503-11.